Infectious Diseases

Medical microbiology is responsible for the detection of bacteria, viruses, fungi, and parasites from patient samples. Depending on the location of the infection, blood, stool, urine, respiratory secretions, or samples taken during an operation, are the starting point for the diagnostics that can be carried out using microscopic, cultural, serological, and molecular methods. With the latest microbiological methods and the latest laboratory technology, we can detect a wide range of pathogens.

Fast and accurate diagnosis is key in critical care settings and for immuno-compromised patients. A Eurofins company has developed Target Enriched Multiplex PCR (TEM-PCR^TM) proprietary technology to improve patient outcomes thanks to fast turnaround, higher sensitivity and higher specificity. The method offers simplicity due to single-sample collection and identifies difficult to culture pathogens. Different specimens are possible with this technology and no bacterial isolation is required.

At Eurofins clinical diagnostics laboratories we are able to identify viral and bacterial pathogens from a single specimen using our TEM-PCR^TM technology. Co-detection allows physicians to administer appropriate treatment, i.e. antibiotic or antiviral therapy. This evidence-based approach translates into improved quality and cost effectiveness of patient care.

Genotypic testing at Eurofins laboratories permits the identification of individual antibiotic resistance and response. Detection of a gene resistant target can provide useful information to guide the appropriate course of action to successfully treat the infection. Genotypic characterization of Antimicrobial resistance (AMR) is based on seventeen genes associated with resistance to beta-lactams, quinolones and macrolides. Depending on the results, an optimal therapy for the patient will be recommended.

How antiviral drugs and antibiotics are metabolized by an individual patient can also be investigated with Eurofins pharmacogenetics testing. Based on the results of the tests, physicians can stratify patients and administer the correct dosage depending on the patient’s drug metabolism profile.